IDEXX Laboratories Inc IDXX

Morningstar Rating
$518.53 +0.22 (0.04%)
View Full Chart

Company Report

Idexx Could Feel Chill as Pet Owners Face Rising Cost of Living

Idexx Laboratories has steadily increased its scale and reach in the veterinary diagnostic lab business to dig a wide moat. It is well positioned to benefit from two key trends. First, pet ownership has grown, offering a secular tailwind since the late 1980s. Moreover, pet owners have generally demonstrated greater willingness to spend more on their animals, having more than tripled spending on pet products and services since 1994.

Price vs Fair Value

IDXX is trading at a LOCK|g%%&&Dn premium.
Price
$517.75
Fair Value
LOCK|#?
Uncertainty
LOCK|D&Rs>
1-Star Price
LOCK|#.&j
5-Star Price
LOCK|w&
Economic Moat
LOCK|mC
Capital Allocation
LOCK|N<yXLx!

Bulls Say, Bears Say

Bulls

Unlike human healthcare, pet health services and products require cash payments—thereby bypassing the reimbursement issues and pricing pressure associated with third-party payers.

Bears

International sales account for a substantial chunk of Idexx's total revenue; as the US dollar strengthens, Idexx would feel the pain on its top and bottom lines.

News

Articles & Videos

Trading Information

Previous Close Price
$517.75
Day Range
$516.64–523.83
52-Week Range
$501.00–769.28
Bid/Ask
$518.14 / $518.54
Shares Outstanding
78.78M
Market Cap
$40.96B
Volume/Avg
151,755 / 568,539

Key Statistics

Price/Earnings (Normalized)
38.49
Price/Sales
9.12
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
2.88%

Company Profile

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Mid Growth
Total Number of Employees
11,000

Competitors

Valuation

Metric
IDXX
MRK
ZTS
Price/Earnings (Normalized)
38.4944.8010.50
Price/Book Value
25.428.479.09
Price/Sales
9.125.363.13
Price/Cash Flow
27.2816.109.28
Price/Earnings
IDXX
MRK
ZTS

Financial Strength

Metric
IDXX
MRK
ZTS
Quick Ratio
0.730.711.57
Current Ratio
1.171.323.08
Interest Coverage
38.634.2814.29
Quick Ratio
IDXX
MRK
ZTS

Profitability

Metric
IDXX
MRK
ZTS
Return on Assets (Normalized)
35.22%6.27%18.78%
Return on Equity (Normalized)
76.64%16.68%70.42%
Return on Invested Capital (Normalized)
45.73%9.82%23.70%
Return on Assets
IDXX
MRK
ZTS

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
LOCK|#$wY@@V#LOCK|^?h$241B
Danaher Corp
DHR
LOCK|CK!Ct^qDLOCK|hkb$149B
Agilent Technologies Inc
A
LOCK|Y#q@HV^HLOCK|?C?$47B
IQVIA Holdings Inc
IQV
LOCK|<WSwT?&LOCK|k!d#?$43B
Waters Corp
WAT
LOCK|#!#^%&LOCK|NVc$42B
Illumina Inc
ILMN
LOCK|Hx$DVMlLOCK|Y?X!$40B
Mettler-Toledo International Inc
MTD
LOCK|XRm&CKN$LOCK|$#KH$30B
Quest Diagnostics Inc
DGX
LOCK|T&dP@<wLOCK|d>ckQ$26B
Labcorp Holdings Inc
LH
LOCK|C!&<&?tLOCK|Nyx<$25B

Sponsor Center